HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Salvatore, P. Articles by Accili, D. Search for Related Content PubMed PubMed Citation Articles by Salvatore, P. Articles by Accili, D. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 12, 6989-6997, March 20, 1998

Identification of sirm, a Novel Insulin-regulated SH3 Binding Protein That Associates with Grb-2 and FYN

Paola Salvatore, Carla R. Hanash, Yoshiaki Kido, Yumi Imai^¶, and Domenico Accili

From the  Developmental Endocrinology Branch, NICHHD, National Institutes of Health, Bethesda, Maryland 20892 and ^¶ Division of Endocrinology, University of North Carolina Medical School, Chapel Hill, North Carolina 27514

We have previously developed a mouse model of insulin-resistant diabetes by targeted inactivation of the insulin receptor gene. During studies of gene expression in livers of insulin receptor-deficient mice, we identified a novel cDNA, which we have termed sirm (Son of Insulin Receptor Mutant mice). sirm is largely, albeit not exclusively, expressed in insulin-responsive tissues. Insulin is a potent modulator of sirm expression, and sirm mRNA levels correlate with tissue sensitivity to insulin. The product of the sirm gene is a serine/threonine-rich protein with several proline-rich motifs and an NPNY motif, conforming to the consensus sequence recognized by the phosphotyrosine binding domains of insulin receptor substrate and Shc proteins. However, Sirm bears no extended homologies with other known proteins. Based on the sequences of the proline-rich domains, we sought to determine whether Sirm binds to the SH3 domains of FYN and Grb-2. We demonstrate here that Sirm binds to FYN and Grb-2 in 3T3-L1 adipocytes and that insulin treatment results in the dissociation of the Sirm·FYN and Sirm·Grb-2 complexes. We also show that Sirm is a substrate for the kinase activity of FYN in vitro. Based on the patterns of expression of sirm, its regulation by insulin, and the interactions with molecules in the insulin signaling pathway, we surmise that Sirm plays a role in modulating tissue sensitivity to insulin.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Nakae, B.-C. Park, and D. Accili Insulin Stimulates Phosphorylation of the Forkhead Transcription Factor FKHR on Serine 253 through a Wortmannin-sensitive Pathway J. Biol. Chem., June 4, 1999; 274(23): 15982 - 15985. [Abstract] [Full Text] [PDF]

				M. Iwanishi, M. P. Czech, and A. D. Cherniack The Protein-tyrosine Kinase Fer Associates with Signaling Complexes Containing Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase J. Biol. Chem., December 8, 2000; 275(50): 38995 - 39000. [Abstract] [Full Text] [PDF]

				W. M. W. Cheung, A. H. Chu, P. W. K. Chu, and N. Y. Ip Cloning and Expression of a Novel Nuclear Matrix-associated Protein That Is Regulated during the Retinoic Acid-induced Neuronal Differentiation J. Biol. Chem., May 11, 2001; 276(20): 17083 - 17091. [Abstract] [Full Text] [PDF]